These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11703432)

  • 21. Photocoagulation in diabetic retinopathy. A multicentre study in Sweden.
    Stenkula S
    Acta Ophthalmol Suppl; 1984; 162():1-100. PubMed ID: 6324526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of diabetic maculopathy by argon laser photocoagulation.
    Grey RH
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 4)():424-9. PubMed ID: 3466463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xenon arc photocoagulation for the treatment of diabetic maculopathy. Interim report of a multicentre controlled clinical study.
    Townsend C; Bailey J; Kohner E
    Br J Ophthalmol; 1980 Jun; 64(6):385-91. PubMed ID: 7387963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of hue discrimination loss and diabetic retinopathy.
    Bresnick GH; Condit RS; Palta M; Korth K; Groo A; Syrjala S
    Arch Ophthalmol; 1985 Sep; 103(9):1317-24. PubMed ID: 4038123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors.
    Rema M; Sujatha P; Pradeepa R
    Indian J Ophthalmol; 2005 Jun; 53(2):93-9. PubMed ID: 15976463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracapsular cataract extraction in proliferative diabetic retinopathy.
    Hykin PG; Gregson RM; Stevens JD; Hamilton PA
    Ophthalmology; 1993 Mar; 100(3):394-9. PubMed ID: 8460011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early photocoagulation in patients with either type I or type II diabetes.
    Ferris F
    Trans Am Ophthalmol Soc; 1996; 94():505-37. PubMed ID: 8981711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.
    Kaiser RS; Maguire MG; Grunwald JE; Lieb D; Jani B; Brucker AJ; Maguire AM; Ho AC; Fine SL
    Am J Ophthalmol; 2000 Feb; 129(2):178-85. PubMed ID: 10682970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colour vision in diabetic patients after photocoagulation treatment. A five-year follow-up.
    Mäntyjârvi M
    Acta Ophthalmol (Copenh); 1993 Aug; 71(4):514-8. PubMed ID: 8249584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.
    Arch Ophthalmol; 1985 Dec; 103(12):1796-806. PubMed ID: 2866759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.
    Ophthalmology; 1991 May; 98(5 Suppl):741-56. PubMed ID: 2062510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicentre trial of xenon-arc photocoagulation in the treatment of diabetic retinopathy. A Randomized controlled study. Interim report.
    Cheng H
    Trans Ophthalmol Soc U K (1962); 1975 Jul; 95(2):351-7. PubMed ID: 1064238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photocoagulation of diabetic maculopathy.
    Ivanisević M
    Acta Med Croatica; 1992; 46(2):113-7. PubMed ID: 1384833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photocoagulation for diabetic maculopathy. A randomized controlled clinical trial using the xenon arc. British Multicentre Study Group.
    Diabetes; 1983 Nov; 32(11):1010-6. PubMed ID: 6357901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
    Mason JO; Yunker JJ; Vail R; McGwin G
    Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of blindness in diabetic retinopathy.
    Kohner EM; Barry PJ
    Diabetologia; 1984 Mar; 26(3):173-9. PubMed ID: 6370766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
    Cho WB; Oh SB; Moon JW; Kim HC
    Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual outcome of laser treatment in diabetic retinopathy.
    Shrestha S; Karki DB; Byanju R; Malla OK; Shrestha SM; Pradhananga CL
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):72-80. PubMed ID: 18603990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term effectiveness of photocoagulation for diabetic maculopathy.
    Davies EG; Petty RG; Kohner EM
    Eye (Lond); 1989; 3 ( Pt 6)():764-7. PubMed ID: 2630360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.